Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-14 Purchase | 2024-06-17 09:26 am | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 1,250 | $20.03 | $25,037 | 52,623 (Direct) | View |
2023-08-09 Sale | 2023-08-10 06:50 am | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $18.27 | $965,402 | 17,836 (Direct) | View |
2023-08-02 Sale | 2023-08-03 09:12 am | Syndax Pharmaceuticals Inc | SNDX | Meury William Director | 83,000 | $20.46 | $1,697,810 | 48,000 (Direct) | View |
2023-07-10 Sale | 2023-07-11 09:23 am | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $20.4 | $1,078,068 | 17,836 (Direct) | View |
2023-06-13 Sale | 2023-06-14 4:20 pm | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 577 | $22.31 | $12,873 | 2,628 (Direct) | View |
2023-06-09 Sale | 2023-06-09 5:32 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $21.18 | $1,119,421 | 17,836 (Direct) | View |
2023-05-09 Sale | 2023-05-10 4:11 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $21.41 | $1,131,478 | 17,836 (Direct) | View |
2023-04-10 Sale | 2023-04-12 4:03 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $19.53 | $1,032,237 | 17,836 (Direct) | View |
2023-03-13 Sale | 2023-03-14 4:42 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $22.53 | $1,190,674 | 17,836 (Direct) | View |
2023-02-15 Sale | 2023-02-17 6:09 pm | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 25,000 | $25.84 | $646,093 | 0 (Direct) | View |
2023-02-06 Sale | 2023-02-08 4:49 pm | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 5,959 | $27.64 | $164,697 | 17,659 (Direct) | View |
2023-02-06 Sale | 2023-02-08 4:49 pm | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $26.83 | $1,417,909 | 17,836 (Direct) | View |
2023-02-01 Sale | 2023-02-03 4:59 pm | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 69 | $28.43 | $1,962 | 90,069 (Direct) | View |
2023-01-12 Sale | 2023-01-13 4:44 pm | Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director | 39,000 | $26.84 | $1,046,782 | 32,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-15 Option Award | 2024-05-16 4:04 pm | N/A 2034-05-15 | Syndax Pharmaceuticals Inc | SNDX | Rizo Aleksandra Director | 35,000 | $0 | 35,000 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 146,250 | $0 | 378,409 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A 2034-02-07 | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 214,500 | $22.28 | 378,409 (Direct) | View |
2024-01-31 Other | 2024-02-09 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 1,183 | $17.42 | 123,418 (Direct) | View |
2023-07-31 Other | 2024-02-09 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 862 | $18.12 | 123,418 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 46,700 | $0 | 123,418 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A 2034-02-07 | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 70,000 | $22.28 | 123,418 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D | 47,813 | $0 | 117,188 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A 2034-02-07 | Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D | 69,375 | $22.28 | 117,188 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:04 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director | 17,000 | $0 | 49,000 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:04 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Jarrett Jennifer Director | 17,000 | $0 | 65,000 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:04 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 17,000 | $0 | 65,000 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:04 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meury William Director | 17,000 | $0 | 65,000 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:04 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 17,000 | $0 | 34,836 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:04 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director | 34,000 | $0 | 141,763 (Direct) | View |
2024-02-07 Option Award | 2024-02-09 4:04 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director | 17,000 | $0 | 65,000 (Direct) | View |
2023-08-09 Exercise | 2023-08-10 06:50 am | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $8.77 | 17,836 (Direct) | View |
2023-08-09 Exercise | 2023-08-10 06:50 am | 2027-02-06 N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
2023-08-02 Exercise | 2023-08-03 09:12 am | N/A 2030-02-12 | Syndax Pharmaceuticals Inc | SNDX | Meury William Director | 83,000 | $0 | 48,000 (Direct) | View |
2023-08-02 Exercise | 2023-08-03 09:12 am | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meury William Director | 24,000 | $9.47 | 48,000 (Direct) | View |
2023-08-02 Exercise | 2023-08-03 09:12 am | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meury William Director | 24,000 | $7.88 | 48,000 (Direct) | View |
2023-08-02 Exercise | 2023-08-03 09:12 am | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meury William Director | 35,000 | $7.11 | 48,000 (Direct) | View |
2023-07-10 Exercise | 2023-07-11 09:23 am | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $8.77 | 17,836 (Direct) | View |
2023-07-10 Exercise | 2023-07-11 09:23 am | N/A 2027-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
2023-06-09 Exercise | 2023-06-09 5:32 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 24,582 | $6.38 | 17,836 (Direct) | View |
2023-06-09 Exercise | 2023-06-09 5:32 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 28,273 | $8.77 | 17,836 (Direct) | View |
2023-06-09 Exercise | 2023-06-09 5:32 pm | N/A 2027-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
2023-05-09 Exercise | 2023-05-10 4:11 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $6.38 | 17,836 (Direct) | View |
2023-05-09 Exercise | 2023-05-10 4:11 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
2023-04-10 Exercise | 2023-04-12 4:03 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $6.38 | 17,836 (Direct) | View |
2023-04-10 Exercise | 2023-04-12 4:03 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Director | 52,855 | $0 | 17,836 (Direct) | View |
2023-04-10 Option Award | 2023-04-12 4:02 pm | N/A 2033-04-10 | Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D | 250,000 | $19.35 | 250,000 (Direct) | View |
2023-03-13 Exercise | 2023-03-14 4:42 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $6.38 | 17,836 (Direct) | View |
2023-03-13 Exercise | 2023-03-14 4:42 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $0 | 17,836 (Direct) | View |
2023-02-15 Exercise | 2023-02-17 6:09 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 17,428 | $7.2 | 0 (Direct) | View |
2023-02-15 Exercise | 2023-02-17 6:09 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 7,572 | $6.38 | 0 (Direct) | View |
2023-02-15 Exercise | 2023-02-17 6:09 pm | N/A 2025-06-01 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 25,000 | $25.84 | 0 (Direct) | View |
2023-02-06 Exercise | 2023-02-08 4:49 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 5,959 | $27.64 | 17,659 (Direct) | View |
2023-02-06 Exercise | 2023-02-08 4:49 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 5,959 | $6.38 | 17,659 (Direct) | View |
2023-02-06 Exercise | 2023-02-08 4:49 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $6.38 | 17,836 (Direct) | View |
2023-02-06 Exercise | 2023-02-08 4:49 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 52,854 | $0 | 17,836 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 5:02 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 410,000 | $28.55 | 410,000 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 5:02 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs President, Head of R&D | 32,000 | $28.55 | 32,000 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 5:01 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Madigan Catherine Chief Medical Officer | 110,000 | $28.55 | 110,000 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 5:00 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 110,000 | $28.55 | 110,000 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 4:59 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 90,000 | $28.55 | 90,069 (Direct) | View |
2023-01-31 Other | 2023-02-03 4:59 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 69 | $17.32 | 90,069 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 4:58 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer | 17,000 | $28.55 | 17,000 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 4:57 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director | 32,000 | $0 | 107,763 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 4:56 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director | 16,000 | $0 | 32,000 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 4:55 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meury William Director | 16,000 | $0 | 48,000 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 4:54 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director | 16,000 | $0 | 48,000 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 4:52 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 16,000 | $0 | 48,000 (Direct) | View |
2023-02-02 Option Award | 2023-02-03 4:52 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Jarrett Jennifer Director | 16,000 | $0 | 48,000 (Direct) | View |
2023-01-12 Exercise | 2023-01-13 4:44 pm | N/A 2030-02-12 | Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director | 39,000 | $0 | 32,000 (Direct) | View |
2023-01-12 Exercise | 2023-01-13 4:44 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director | 24,000 | $9.47 | 32,000 (Direct) | View |
2023-01-13 Exercise | 2023-01-13 4:44 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director | 15,000 | $13.58 | 32,000 (Direct) | View |
2022-12-05 Option Award | 2022-12-05 4:41 pm | N/A 2032-12-05 | Syndax Pharmaceuticals Inc | SNDX | Sabus Steve M Chief Commercial Officer | 220,000 | $25.44 | 220,000 (Direct) | View |